Military representatives from six of the countries operating the prestigious 155mm/52-calibre K9 Self-Propelled Howitzer (SPH), developed by Hanwha Aerospace, have convened in Helsinki, Finland, for the annual K9 User Club meeting.For this year’s meeting, the third of its kind since 2022, Finland, w
Lotte Biologics recently announced the signing of a strategic business agreement with NJ Bio, a U.S.-based Contract Research Organization (CRO) specializing in non-clinical and clinical contract research, to provide one-stop Antibody-Drug Conjugate (ADC) services. Established in 2018, NJ Bio, based
Pernod Ricard Korea, the Korean division of the wine and spirits company Pernod Ricard, will operate a pop-up space featuring Glenburgie, a single malt released by its modern classic Scotch whisky brand Ballantine’s, at Lotte World Mall Atrium from January 24 to February 12.Ballantine’s Glenburgie s
On Jan. 19, Dong-A ST NeuroBo Pharmaceuticals announced the commencement of the global Phase 2 Part 2 clinical trial for its Metabolic dysfunction-associated steatohepatitis (MASH) treatment DA-1241.Last May, the company received approval from the U.S. Food and Drug Administration (FDA) for the glob
Celltrion Group has successfully sold the Asia-Pacific (APAC) “Primary Care” business rights, which it acquired from multinational pharmaceutical company Takeda Pharmaceuticals (hereafter Takeda) in 2020, after three years.On Jan. 18, Celltrion concluded a contract with Dong-A Pharmaceutical for the
Hanmi Pharmaceutical Group’s eldest and second sons, President Lim Jong-yoon and President Lim Jong-hoon, have filed an injunction against the merger of Hanmi Group and OCI Group.President Lim Jong-yoon, through the X (formerly Twitter) account of his personal company Corey Group, announced on Jan.
Celltrion has launched an 80-mg dosage form of its biosimilar Yuflyma (adalimumab) for the treatment of autoimmune diseases in the United States.Celltrion said on Jan. 17 that 80 mg is the same high-concentration (100 mg/ml) formulation as the 40 mg version that became available in the United States
Orion is taking its first step into the next-generation anti-cancer drug market by acquiring LegoChem Bio for about 55 billion won.Orion Holdings acquired a 25 percent stake in LegoChem Bio and became the largest shareholder on Jan. 15, according to industry sources on Jan. 16. Orion acquired a tota
Hyundai Motor Group has sold its Chongqing plant in China for about 300 billion won. This has reduced the number of production bases in China from five to three since Hyundai entered the country in 2002. The decision was made to reorganize the structure of its Chinese business, thereby boosting its
Pernod Ricard Korea, the Korean affiliate of the global wine and spirits company Pernod Ricard, announced that it held a special lecture to help build a sustainable bar culture on January 15, 2024.The special lecture was offered as part of the Bar World of Tomorrow training program that Pernod Ricar
JW Pharmaceutical announced on Jan. 15 that it has received approval from the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for a phase 3 clinical trial plan, or investigational new drug (IND), of its gout treatment drug Epaminurad (code name URC102).The Phase 3 clinical trial for Epami
The Ministry of Food and Drug Safety in South Korea announced the launch of the Asia-Pacific Food Regulatory Authority Summit (APFRAS) Secretariat on Jan. 15 to support the activities of the international cooperative body aimed at leading food sector international cooperation and regulatory harmoniz
Hak Cheol Shin, CEO of LG Chem, has been selected as one of the top 100 economic leaders representing the World Economic Forum (WEF). At this year’s forum, CEO Shin will meet with global clients and partners to discuss collaboration strategies for managing the global supply chain and overcoming the
The number of technical regulations notified by World Trade Organization (WTO) member countries in 2023 exceeded 4,000 for the first time ever, a record high, showing that technical barriers to trade were rising among countries.The Korean Agency for Technology and Standards under the Ministry of Tra
Amid the resolution for the merger between the pharmaceutical giant Hanmi Pharmaceutical Group and the materials and energy-focused OCI Group, signs of a potential management dispute have emerged. This comes as a result of opposition from Lim Jong-yoon, the current CEO of Hanmi Pharmaceutical and th
Celltrion’s biosimilar products for the treatment of autoimmune diseases have successively won bids in major European countries.According to Celltrion on Jan. 12, Yuflyma (active ingredient: adalimumab) has successfully won a government bid in Italy. Yuflyma was awarded in the adalimumab government
GC Biopharma Group is approaching close to 5 trillion won in total assets, setting a milestone as the first traditional pharmaceutical group to reach the disclosure threshold for public reporting.According to the electronic disclosure system on Jan. 11, the total assets of GC Biopharma Group, includ
During a press conference at the JP Morgan Healthcare Conference (JPMHC), the world’s largest pharmaceutical and biotech investment event, on Jan. 10 (local time), Celltrion Group Chairman Seo Jung-jin announced that the company plans to establish a healthcare investment fund worth 100 trillion won.
South Korea would be hit hard if China invaded Taiwan and a war broke out, according to a forecast by Bloomberg Economics.On Jan. 9 (local time), Bloomberg Economics, an economic research institute affiliated with Bloomberg News, said the geopolitical crisis in Taiwan could intensify ahead of a pres
According to the BioEconomy Research Center of the Korea Biotechnology Industry Organization on Jan. 10, WuXi Biologics, a leading Chinese biopharmaceutical Contract Development and Manufacturing Organization (CDMO), is confirmed to be constructing a commercial biopharmaceutical raw material product